Heart Disease News and Research

Latest Heart Disease News and Research

British children's sugar intake exceeds current public health recommendations

A new study, being presented at this year's European Congress on Obesity (ECO) in Maastricht, Netherlands (4-7 May), suggests that children in the UK start consuming free sugars (those added to foods and drinks and those occurring naturally in fruit juices, honey and syrups) at a very young age, and that many toddlers' sugar intake exceeds the maximum recommended amount for children aged 4 and older.

2 May 2022

How diet and nutrition impacts lifespan

In a recent study published in the journal Cell, researchers analyzed the association between human longevity to growth and metabolic pathways.

1 May 2022

New cardiac defibrillator implanted under the skin greatly reduces patient complications

High-risk patients who need defibrillators to prevent cardiac arrest can experience fewer complications with a type of device implanted under the skin, a Canadian study has found.

30 Apr 2022

Researchers test a method for delivering genetic material into the body to repair damaged heart muscle

A method for delivering genetic material to the body is being tested as a way to repair damaged heart muscle after a heart attack.

30 Apr 2022

Novel therapy using nitric oxide may be an efficient and safe way to treat multiple metabolic diseases

A novel therapy developed at the University of Alabama at Birmingham ameliorates obesity and Type 2 diabetes in mice fed a high-fat diet.

29 Apr 2022

Exploring happy hypoxia in COVID-19 patients

In a new study, researchers reported that silent hypoxia was not unique to COVID-19.

29 Apr 2022

Dapagliflozin did not reduce risks in patients hospitalized with COVID-19

In a recent randomized clinical trial of hospitalized patients with COVID-19 and cardio-metabolic risk factors, the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin did not significantly reduce patients' risk of organ failure, kidney problems, or death compared with placebo, although numerically fewer participants treated with dapagliflozin experienced these outcomes. The findings are published in CJASN.

29 Apr 2022

Clinical characteristics of immunocompromised patients infected with the SARS-CoV-2 Omicron variant

Researchers examined the characteristics and outcomes of COVID-19 in immunocompromised patients.

29 Apr 2022

Lower COVID-19 mortality among physically active individuals in Sub-Saharan Africa

Researchers enlisted the benefits of physical activity and being outdoors in reducing the incidence, prevalence, and severity of COVID-19 among low-income populations.

29 Apr 2022

Understanding sex differences in the pathophysiology of SARS-CoV-2 infection

A recent study published in the journal Immunology analyzed whether sex mattered in the immune response to SARS-CoV-2.

29 Apr 2022

New workflow identifies hidden genetic connections that could improve personalized medicine for IBD

All humans carry genetic variations in their DNA, called Single Nucleotide Polymorphisms (SNPs) that can underlie susceptibility to diseases such as diabetes and cancer.

28 Apr 2022

Gum Health Day 2022 calls for prevention, early detection, and effective treatment of gum diseases

"Treat your gums" is the slogan for Gum Health Day 2022, a worldwide awareness campaign organised by the European Federation of Periodontology (EFP).

28 Apr 2022

Specific genes that play important role in schizophrenia identified

Schizophrenia is a serious psychiatric disorder that starts in late adolescence or early adulthood and affects around 1 in 300 people worldwide, according to the World Health Organization.

28 Apr 2022

Study offers critical clues into longstanding mystery of deep sleep

Healthy sleep is a basic physiologic need. In its absence, a myriad of processes in the body can go terribly awry. Chronic sleep problems have been linked to mental health disorders, cardiovascular disease, type 2 diabetes, and obesity, among other conditions.

28 Apr 2022

NIH awards $10.9 million COBRE grant to support Nemours Children's 'well beyond medicine' strategy

The National Institutes of Health (NIH) recently awarded a Phase 1, 5-year $10.9 million Center of Biomedical Research Excellence (COBRE) award, entitled Research Expanding Access to Child Health (REACH) Center to Anne Kazak, PhD, Enterprise Director, and Melissa Alderfer, PhD, Director of the Center for Healthcare and Delivery Science (CHDS) at Nemours Children's Health.

28 Apr 2022

Heart Disease News and Research

Latest Heart Disease News and Research

British children's sugar intake exceeds current public health recommendations

How diet and nutrition impacts lifespan

New cardiac defibrillator implanted under the skin greatly reduces patient complications

Researchers test a method for delivering genetic material into the body to repair damaged heart muscle

Novel therapy using nitric oxide may be an efficient and safe way to treat multiple metabolic diseases

Exploring happy hypoxia in COVID-19 patients

Dapagliflozin did not reduce risks in patients hospitalized with COVID-19

Clinical characteristics of immunocompromised patients infected with the SARS-CoV-2 Omicron variant

Lower COVID-19 mortality among physically active individuals in Sub-Saharan Africa

Understanding sex differences in the pathophysiology of SARS-CoV-2 infection

New workflow identifies hidden genetic connections that could improve personalized medicine for IBD

Gum Health Day 2022 calls for prevention, early detection, and effective treatment of gum diseases

Specific genes that play important role in schizophrenia identified

Study offers critical clues into longstanding mystery of deep sleep

NIH awards $10.9 million COBRE grant to support Nemours Children's 'well beyond medicine' strategy

AI system can enhance images of mouse brain cells in action

CDC report shows the prevalence of hypertensive disorders in pregnancy among delivery hospitalizations

Two reports highlight the need for effective interventions to prevent excess COVID-19 deaths

Study investigates intestinal ischemia in COVID-19 patients

Aspirin for non-obstructive coronary artery disease does not reduce major cardiovascular events

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Heart Disease News and Research

Latest Heart Disease News and Research

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in